檢索結果 - Alessandra Iurlo
- Showing 1 - 20 results of 35
- Go to Next Page
-
1
Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemothe... 由 Cristina Bucelli, Daniele Cattaneo, Valeria Ferla, Manuela Zappa, Caterina de Benedittis, Simona Soverini, Alessandra Iurlo
發表在 Case Reports in Hematology (2017-01-01)獲取全文
Article -
2
-
3
Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase 由 Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno, Giuliana Alimena
發表在 Haematologica (2016-06-01)獲取全文
Article -
4
P1002: PROTEOMIC SCREENING IDENTIFIES MEGAKARYOCYTE DERIVED PF4/CXCL4 AS A CRITICAL DRIVER OF MYELOFIBROSIS 由 Alessandro Malara, Vittorio Abbonante, Francesca Rossella Calledda, Daniele Capitanio, Daniele Cattaneo, Alessandra Iurlo, Cecilia Gelfi, Alessandra Balduini
發表在 HemaSphere (2023-08-01)獲取全文
Article -
5
-
6
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia 由 Sara Galimberti, Elisabetta Abruzzese, Giacomo Luci, Claudia Baratè, Luigia Luciano, Alessandra Iurlo, Giovanni Caocci, Riccardo Morganti, Fabio Stefanelli, Antonello Di Paolo
發表在 Pharmaceutics (2024-03-01)獲取全文
Article -
7
HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases 由 Stefano Fiori, Elisabetta Todisco, Safaa Ramadan, Federica Gigli, Patrizia Falco, Alessandra Iurlo, Cristiano Rampinelli, Giorgio Croci, Stefano A. Pileri, Corrado Tarella
發表在 Biology (2021-02-01)獲取全文
Article -
8
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy 由 Carlo Alberto Maronese, Carlo Alberto Maronese, Federica Derlino, Chiara Moltrasio, Daniele Cattaneo, Daniele Cattaneo, Alessandra Iurlo, Angelo Valerio Marzano, Angelo Valerio Marzano
發表在 Frontiers in Medicine (2024-01-01)獲取全文
Article -
9
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance 由 Massimo Breccia, Francesca Palandri, Paola Guglielmelli, Giuseppe Alberto Palumbo, Alessandra Malato, Francesco Mendicino, Alessandra Ricco, Emanuela Sant’Antonio, Mario Tiribelli, Alessandra Iurlo
發表在 Current Oncology (2022-07-01)獲取全文
Article -
10
P989: NEWLY IDENTIFIED ROLES FOR PIEZO1 MECHANOSENSOR IN CONTROLLING NORMAL MEGAKARYOCYTE DEVELOPMENT AND IN PRIMARY MYELOFIBROSIS 由 Vittorio Abbonante, Iris A. Karkempetzaki, Christian A. DI Buduo, Nasi Huang, Daniele Cattaneo, Christina Ward, Shinobu Matsuura, Alessandra Iurlo, Katya Ravid, Alessandra Balduini
發表在 HemaSphere (2023-08-01)獲取全文
Article -
11
Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease... 由 Julia T. Geyer, Elizabeth Margolskee, Spencer A. Krichevsky, Daniele Cattaneo, Leonardo Boiocchi, Paola Ronchi, Francesca Lunghi, Joseph M. Scandura, Maurilio Ponzoni, Robert P. Hasserjian, Umberto Gianelli, Alessandra Iurlo, Attilio Orazi
發表在 Haematologica (2020-05-01)獲取全文
Article -
12
How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis f... 由 Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, Fabrizio Pane, Alessandra Iurlo, Paolo Foggi, Alessia Cirilli, Antonietta Colatrella, Marcello Cuomo, Lucia Gozzo, Valentina Summa, Paolo Corradini, Pierluigi Russo, the AIFA’s Monitoring Registries Group
發表在 Cancer Medicine (2020-06-01)獲取全文
Article -
13
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 由 Simona Soverini, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio, Sara Galimberti, Antonella Gozzini, Alessandra Iurlo, Luigiana Luciano, Patrizia Pregno, Gianantonio Rosti, Giuseppe Saglio, Fabio Stagno, Mario Tiribelli, Paolo Vigneri, Giovanni Barosi, Massimo Breccia
發表在 Journal of Hematology & Oncology (2019-12-01)獲取全文
Article -
14
Chronic Myeloid Leukemia Patient’s Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experienc... 由 Lidia Borghi, Sara Galimberti, Claudia Baratè, Massimiliano Bonifacio, Enrico Capochiani, Antonio Cuneo, Franca Falzetti, Alessandra Iurlo, Francesca Lunghi, Claudia Minotto, Ester Maria Orlandi, Giovanna Rege-Cambrin, Simona Sica, Sharon Supekar, Jens Haenig, Elena Vegni
發表在 Frontiers in Psychology (2019-02-01)獲取全文
Article -
15
P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLA... 由 Justin M. Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro Vannucchi, Prithviraj Bose, Rosa Ayala Diaz, Anna B. Halpern, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani
發表在 HemaSphere (2023-08-01)獲取全文
Article -
16
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera 由 Tiziano Barbui, Arianna Ghirardi, Victoria Empson, Francesca Fenili, Giuseppe Gaetano Loscocco, Annalisa Condorelli, Alessandra Iurlo, Daniele Cattaneo, Elena Rossi, Valerio De Stefano, Paola Guglielmelli, Christoph Klade, Heinz Gisslinger, Alessandro Rambaldi, Joseph M. Scandura, Alessandro Maria Vannucchi
發表在 Blood Cancer Journal (2025-08-01)獲取全文
Article -
17
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib 由 Giacomo Coltro, Giulio Capecchi, Margherita Maffioli, Francesco Mannelli, Barbara Mora, Alessandro Atanasio, Alessandra Iurlo, Chiara Maccari, Mirko Farina, Elena Nacca, Marianna Caramella, Leonardo Signori, Miriam Borella, Lorenza Bertù, Maria Esposito, Paola Guglielmelli, Francesco Passamonti, Alessandro Maria Vannucchi
發表在 Haematologica (2024-05-01)獲取全文
Article -
18
SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability 由 Manuela Mancini, Sara De Santis, Cecilia Monaldi, Fausto Castagnetti, Miriam Iezza, Alessandra Iurlo, Daniele Cattaneo, Sara Galimberti, Marco Cerrano, Isabella Capodanno, Massimiliano Bonifacio, Maura Rossi, Claudio Agostinelli, Manja Meggendorfer, Torsten Haferlach, Michele Cavo, Gabriele Gugliotta, Simona Soverini
發表在 Clinical and Translational Medicine (2025-04-01)獲取全文
Article -
19
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy 由 Marianna De Muro, Annelot Julia Janssen, Sergio Amadori, Paolo de Fabritiis, Dante Sabatino, Pasquale Niscola, Lorenza Torti, Malgorzata Monika Trawinska, Cristiano Tesei, Felice Bombaci, Mario Tarricone, Monica Bocchia, Carmen Fava, Sara Galimberti, Alessandra Iurlo, Luigia Luciano, Elisabetta Abruzzese
發表在 Therapeutic Advances in Hematology (2023-09-01)獲取全文
Article -
20
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells 由 Paola Pacelli, Adele Santoni, Anna Sicuranza, Elisabetta Abruzzese, Valentina Giai, Monica Crugnola, Mario Annunziata, Sara Galimberti, Alessandra Iurlo, Luigiana Luciano, Federica Sorà, Carmen Fava, Elena Bestoso, Cristina Marzano, Alessandra Cartocci, Marzia Defina, Vincenzo Sammartano, Emanuele Cencini, Donatella Raspadori, Monica Bocchia
發表在 Frontiers in Pharmacology (2023-05-01)獲取全文
Article
